|
GOLPH3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81670234411513E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.61959376202503E-12 |
| Normal-vs-Stage2 |
3.392100E-04 |
| Normal-vs-Stage3 |
2.611900E-02 |
| Normal-vs-Stage4 |
1.253530E-02 |
| Stage1-vs-Stage2 |
4.728000E-01 |
| Stage1-vs-Stage3 |
1.917610E-02 |
| Stage1-vs-Stage4 |
5.058800E-01 |
| Stage2-vs-Stage3 |
2.039400E-01 |
| Stage2-vs-Stage4 |
8.813800E-01 |
| Stage3-vs-Stage4 |
3.844600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.24410506738582E-11 |
| Normal-vs-AfricanAmerican |
1.22989951556463E-10 |
| Normal-vs-Asian |
1.237240E-03 |
| Caucasian-vs-AfricanAmerican |
4.256600E-01 |
| Caucasian-vs-Asian |
9.825400E-01 |
| AfricanAmerican-vs-Asian |
7.909800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.71129818385907E-13 |
| Normal-vs-Female |
3.644700E-04 |
| Male-vs-Female |
2.494400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.46169999940093E-08 |
| Normal-vs-Extreme_Weight |
7.0416006359153E-11 |
| Normal-vs-Obese |
7.75259999999944E-05 |
| Normal-vs-Extreme_Obese |
3.95840000000369E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.272200E-01 |
| Normal_Weight-vs-Obese |
1.012420E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.927800E-01 |
| Extreme_Weight-vs-Obese |
6.634100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.570800E-01 |
| Obese-vs-Extreme_Obese |
1.942430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.236400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.54430000010031E-07 |
| Normal-vs-Age(61-80Yrs) |
7.27196081129478E-14 |
| Normal-vs-Age(81-100Yrs) |
1.48759999996084E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.820000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.451900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.779900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.176900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.402800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.459600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.0240701316161E-13 |
| Normal-VS-Type2 PRCC |
4.45119996417276E-09 |
| Normal-VS-KIRP CIMP |
1.695580E-01 |
| Normal-VS-Unclassified PRCC |
2.864800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.290200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.853700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.728200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.525620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.290200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.980000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.57059945446758E-10 |
| Normal-vs-N1 |
1.093840E-01 |
| Normal-vs-N2 |
2.30900000000034E-05 |
| N0-vs-N1 |
3.360300E-03 |
| N0-vs-N2 |
5.370800E-01 |
| N1-vs-N2 |
7.767900E-02 |
|
|
